J.L. Bainbridge & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$7.55M |
| 2 |
nVent Electric
NVT
|
+$6.42M |
| 3 |
Blackstone
BX
|
+$3.9M |
| 4 |
Eli Lilly
LLY
|
+$1.7M |
| 5 |
AbbVie
ABBV
|
+$269K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$20.8M |
| 2 |
Comcast
CMCSA
|
+$16.3M |
| 3 |
Microsoft
MSFT
|
+$2.57M |
| 4 |
Warner Bros
WBD
|
+$2.23M |
| 5 |
Target
TGT
|
+$1.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.04% |
| 2 | Industrials | 19.55% |
| 3 | Communication Services | 14.15% |
| 4 | Financials | 11.85% |
| 5 | Healthcare | 7.35% |
Similar funds
J.L. Bainbridge & Co's Q4 2023 Portfolio in Review
As of Q4 2023, J.L. Bainbridge & Co held 91 positions worth $817M, up 9.5% from $746M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
J.L. Bainbridge & Co withdrew a net $32.7M in Q4 2023, closing 3 positions and reducing 29 holdings. Its most notable exit was iShares iBonds Dec 2023 Term Corporate ETF, an estimated $1.04M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Industrials and Communication Services.
Against the trend, J.L. Bainbridge & Co opened a new position in AbbVie worth $286K.
- J.L. Bainbridge & Co's largest Q4 2023 buy was AbbVie: 1,845 shares worth $286K.
- J.L. Bainbridge & Co added most to Cigna in Q4 2023, an estimated $7.55M increase.
- J.L. Bainbridge & Co's biggest Q4 2023 reduction was AT&T, cutting an estimated $20.8M.
- J.L. Bainbridge & Co fully exited iShares iBonds Dec 2023 Term Corporate ETF in Q4 2023, selling an estimated $1.04M.
- J.L. Bainbridge & Co's ten largest holdings make up 63% of its $817M portfolio in Q4 2023.
- J.L. Bainbridge & Co opened 9 new positions and closed 3 in Q4 2023.
- J.L. Bainbridge & Co's portfolio value rose 9.5% quarter-over-quarter to $817M.
Based on J.L. Bainbridge & Co's 13F filing for Q4 2023, filed 12 Feb 2024.